Webcasts

New Horizons in Reducing Cardiovascular Disease Risk in Patients with Type 2 Diabetes with SGLT-2, GLP-1 RAs and DPP-4 Based Therapies
Released on 6/14/19
Expires on 6/14/20
Link to webcast
Changing Landscape of GLP-1 Receptor Agonists on Glycemic Control, Weight Reduction and Cardiovascular Outcomes in Individuals with Diabetes
Released on 6/12/19
Expires on 6/12/20
Link to webcast
Changing Landscape of Treatment Options for Migraine with Monoclonal Antibodies Targeting Calcitonin Gene-related Peptide (CGRP) Pathway or its Receptor
Released on 3/22/19
Expires on 3/22/20
Link to webcast
Emerging Newer Therapies in the Management of Lung Function, Exacerbations, Safety and Tolerability in Patients with COPD
Released on 8/9/18
Expires on 8/9/19
Link to webcast
Emerging Anti-Interleukin 5 (IL-5) and IL-5Ra Based Biological Therapies: Efficacy, Safety and Future Perspectives in Severe Eosinophilic Asthma
Released on 7/12/18
Expires on 7/12/19
Link to webcast
Emerging Interleukin-5 (IL-5) or its Receptor (IL-5R) Monoclonal Antibody Based Biological Therapies for Severe or Poorly Controlled Asthma
Released on 6/29/18
Expires on 6/29/19
Link to webcast
Emerging Strategies in the Diagnosis and Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)
Released on 6/19/18
Expires on 6/19/19
Link to webcast
New Era in the Lipid Lowering Treatment with PCSK9 Inhibitors (Evolocumab and Alirocumab) in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia
Released on 5/11/18
Expires on 5/11/19
Link to webcast
Emerging Strategies in the Diagnosis and Treatment of Interstitial Lung Disease (ILD)
Released on 5/10/18
Expires on 5/10/19
Link to webcast
Emerging Strategies in the Anti–Interleukin-5 Monoclonal Antibody Based Targeted Therapies for Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Released on 2/6/18
Expires on 2/6/19
Link to webcast
Efficacy and Safety of Fixed-ratio Combination of Insulin Degludec and Liraglutide (IDegLira) and Insulin Glargine and Lixisenatide (IGlarLixi) in Patients with Type 2 Diabetes
Released on 11/29/17
Expires on 11/29/18
Link to webcast
Emerging Strategies in the Monoclonal Antibodies Targeting Calcitonin Gene-related Peptide (CGRP) or its Receptor in the Preventive Treatment of Migraine
Released on 11/17/17
Expires on 11/17/18
Link to webcast
Emerging Strategies in the Management of Dyslipidemia in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia: PCSK9 Inhibitors (Evolocumab and Alirocumab)
Released on 10/10/17
Expires on 10/10/18
Link to webcast
Changing Landscape of Biological Therapies for Psoriasis: Promising Efficacy of Interleukin-17 (IL-17) and IL-2 Pathway Inhibitors
Released on 9/20/17
Expires on 9/20/18
Link to webcast
Advances in Biological Therapy of Crohn's Disease and Ulcerative Colitis
Released on 8/10/17
Expires on 8/10/18
Link to webcast
Emerging Immunotherapeutic Strategies for Poorly Controlled Asthma
Released on 7/20/17
Expires on 7/20/18
Link to webcast
Advances in GLP-1 Receptor Agonists, Insulins and SGLT-2 Inhibitors in the Treatment of Diabetes
Released on 5/12/17
Expires on 5/12/18
Link to webcast
Individualized Treatment Options for Type 2 Diabetes: Comparative Effectiveness of GLP-1 Receptor Agonists on Glycemic Control, Weight Reduction and Cardiovascular Risk
Released on 4/20/17
Expires on 4/20/18
Link to webcast
Emerging Strategies in the Treatment of Parkinson's Disease: Management of Non-Motor, Motor and Psychotic Symptoms
Released on 2/24/17
Expires on 2/24/18
Link to webcast
Emerging Biological Therapies for Atopic Dermatitis in Children and Adults
Released on 2/15/17
Expires on 2/15/18
Link to webcast
Biological Therapies for PsA, Osteoarthritis, SLE and Spondyloarthritis: Comparative Effectiveness Based on Treatment Profiles and ACR/EULAR Recommendations
Released on 12/15/16
Expires on 12/15/17
Link to webcast
Emerging Interleukin5 (IL5) Antagonists Based Therapies for Eosinophilic Asthma
Released on 10/31/16
Expires on 10/31/17
Link to webcast
Emerging Biological Therapies for Psoriasis: Promising Efficacy of Interleukin‐17 (IL‐17) and IL‐23 Pathway Inhibitors
Released on 10/28/16
Expires on 10/28/17
Link to webcast
3rd Annual Symposium on Individualized Novel Disease-Modifying Treatment Options for Multiple Sclerosis Released on 10/26/2016
Expires on 10/26/2017
Link to webcast
Update on Novel Antiepileptic Drugs in Treatment of Epilepsy
Released on 9/28/16
Expires on 9/28/17
Link to webcast
Emerging Immunotherapeutic Strategies for Poorly Controlled Asthma
Released on 7/20/2016
Expires on 7/20/2017
Link to webcast
Update on GLP-1 Receptor Agonists in the Management of Type 2 Diabetes Mellitus
Released on 7/7/16
Expires on 7/7/17
Link to webcast